Rufini Vittoria, Salvatori Massimo, Fadda Guido, Pinnarelli Luigi, Castaldi Paola, Maussier Maria Lodovica, Galli Guido
Department of Nuclear Medicine, Catholic University of Sacred Heart, Rome, Italy.
Cancer. 2007 Sep 15;110(6):1209-17. doi: 10.1002/cncr.22913.
An insular growth pattern may be observed focally both in papillary and follicular thyroid carcinoma. The aim of the current study was to determine whether a greater extension of the insular component (IC) influences different clinical and histologic features at diagnosis, and a different tumor aggressiveness in terms of frequency in the occurrence of metastases as well as survival.
Thirty-three patients with histopathologic findings consistent with IC were included in the study. IC was focal (<50% of the tumor area) in 16 patients and predominant (>50% of the tumor area) in 17 patients. These 2 groups were compared with a control group of 66 patients with differentiated thyroid carcinoma.
At diagnosis, carcinomas with predominant IC differed from those with focal IC with regard to greater tumor size and a higher frequency of extrathyroidal extension and distant metastases. Patient follow-up ranged from 5 to 188 months. The cumulative rate of distant metastases was significantly higher in patients with predominant IC. At the time of last follow-up, carcinomas with predominant IC demonstrated a lesser frequency of disease-free outcome (P = .002) and a higher number of tumor-related deaths (P = .002), either when distant metastases were present (P = .03) or absent (P = .05) at the time of diagnosis.
The presence of predominant IC is associated with a poor prognosis in terms of ongoing disease or death. Predominant IC should be considered a separate entity from not only the classical papillary or follicular carcinomas but also the focal IC tumor.
在甲状腺乳头状癌和滤泡状癌中均可局灶性观察到岛状生长模式。本研究的目的是确定岛状成分(IC)范围的扩大是否会影响诊断时不同的临床和组织学特征,以及在转移发生频率和生存率方面不同的肿瘤侵袭性。
本研究纳入了33例组织病理学结果符合IC的患者。16例患者的IC为局灶性(<肿瘤面积的50%),17例患者的IC为主导性(>肿瘤面积的50%)。将这两组与66例分化型甲状腺癌患者的对照组进行比较。
在诊断时,主导性IC的癌与局灶性IC的癌在肿瘤更大、甲状腺外扩展和远处转移频率更高方面存在差异。患者随访时间为5至188个月。主导性IC患者的远处转移累积率显著更高。在最后随访时,无论诊断时是否存在远处转移,主导性IC的癌无病结局频率更低(P = 0.002),肿瘤相关死亡数更高(P = 0.002)(存在远处转移时P = 0.03,不存在远处转移时P = 0.05)。
主导性IC的存在与疾病进展或死亡方面的不良预后相关。主导性IC不仅应被视为与经典乳头状癌或滤泡状癌不同的实体,也应被视为与局灶性IC肿瘤不同的实体。